STOCK TITAN

Semilux International (SELX) Financials

SELX
FY2024 annual
Revenue $3.7M +241.8% YoY
Net Income -$3.7M -125.2% YoY
EPS (Diluted) -$0.10 YoY not available
Free Cash Flow -$578K +71.3% YoY
Source SEC Filings (10-K/10-Q) Latest period FY2024, ended Dec 31, 2024 Reported Currency USD FYE December

Newest figures come from the 20-F for FY2024, filed Nov 10, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SELX SEC filings page.

Semilux International (SELX) reported $3.7M in revenue for fiscal year 2024, up 241.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 2 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SELX FY2024

Semilux expanded sales but remained structurally loss-making, while shrinking assets and rising leverage tightened the balance-sheet cushion.

Operating cash flow moved from -$1.244M to $66K, indicating that operating cash conversion improved temporarily despite worsening earnings. Free cash flow remained -$578K after $644K of capital expenditures, so the cash improvement did not make the business self-funding.

Revenue reached $3.667M as gross margin improved to -23.7%, indicating better economics per reported dollar. But selling, general and administrative expense reached $2.466M while operating margin remained -147.0%, so growth has not yet absorbed overhead.

Assets fell to $9.611M while liabilities rose to $8.217M, leaving far less balance-sheet backing for operations. Debt-to-equity reached 1.6x while current ratio fell to 1.1x, showing greater reliance on liabilities and less short-term cushion.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 33 / 100
Financial Health Score 33/100

Scored against operating companies for FY2024. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Semilux International's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
24

Semilux International's reported operating margin for fiscal year 2024 is below the lowest share of revenue this page publishes, so the figure is not shown here. This dimension scores 24/100.

Growth
99

Semilux International's revenue surged 241.8% year-over-year to $3.7M, reflecting rapid business expansion. This strong growth earns a score of 99/100.

Leverage
36

Semilux International has a moderate D/E ratio of 1.65. This balance of debt and equity financing earns a leverage score of 36/100.

Liquidity
22

Semilux International's current ratio of 1.07 is below the typical benchmark, resulting in a score of 22/100. However, the company holds substantial cash reserves (52% of current liabilities), which buffers actual liquidity risk. Large mature operators often run tight current ratios by design.

Cash Flow
4

While Semilux International generated $66K in operating cash flow, capex of $644K consumed most of it, leaving -$578K in free cash flow. This results in a low score of 4/100, reflecting heavy capital investment rather than weak cash generation.

Returns
13

Semilux International posts a -645.1% return on equity (ROE), meaning it loses $645 for every $100 of shareholders' equity. This results in a returns score of 13/100. This is down from -22.3% the prior year.

Altman Z-Score Distress
-1.08

Semilux International scores -1.08, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($14.7M) relative to total liabilities ($8.2M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
4/9

Semilux International passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Mixed
N/A

Semilux International reported a net loss of $3.7M while generating $66K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Semilux International reported an operating loss of $5.4M against $101K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q4 2024.

Cash & Balance Sheet

Cash & Debt
$3.6M
YoY-45.7%
QoQ-45.7%

Semilux International held $3.6M in cash against $938K in long-term debt as of Q4 2024.

Shares Outstanding
38M
YoY+24.4%
QoQ+24.4%

Semilux International had 38M shares outstanding in Q4 2024. This represents an increase of 24.4% from the same quarter a year earlier. Against the prior quarter it is up 24.4%.

Free Cash Flow

Not reported for Q4 2024.

Dividends Per Share

Not reported for Q4 2024.

Margins & Returns

None of these metrics is reported for Q4 2024.

Capital Allocation

None of these metrics is reported for Q4 2024.

SELX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SELX quarterly income statement
MetricQ4'2420-FQ4'23

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

SELX Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SELX quarterly balance sheet
MetricQ4'2420-FQ4'23
Total Assets$9.6M-34.4%$14.7M
Current Assets$7.4M-36.5%$11.6M
Cash & Equivalents$3.6M-45.7%$6.6M
Inventory$487K-68.8%$1.6M
Accounts Receivable$200K+10.5%$181K
Total Liabilities$8.2M+51.5%$5.4M
Current Liabilities$6.9M+71.2%$4.0M
Non-Current Liabilities$1.3M-4.4%$1.4M
Long-Term Debt$938K-33.4%$1.4M
Total Equity$570K-92.2%$7.3M
Retained Earnings-$5.1M-234.2%-$1.5M

Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments, Goodwill.

SELX Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SELX quarterly cash flow statement
MetricQ4'2420-FQ4'23

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

SELX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SELX quarterly financial ratios
MetricQ4'2420-FQ4'23
Current Ratio1.07-1.8x2.89
Debt-to-Equity1.65+1.5x0.19

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Semilux International SELX FY2024 $3.7M -$3.7M N/A $14.7M 33/100
Research Frontiers Inc REFR FY2025 $1.1M -$2.0M N/A $14.3M 51/100
Data I.O. DAIO FY2025 $21.5M -$5.2M -24.3% $29.5M 46/100
Cps Technologie CPSH FY2025 $32.6M $420K 1.3% $74.4M 46/100
Maris Tech Ltd. MTEK FY2025 $1.3M -$5.4M N/A $11.7M 40/100

Frequently Asked Questions

What is Semilux International's annual revenue?

Semilux International (SELX) reported $3.7M in total revenue for fiscal year 2024. This represents a 241.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Semilux International's revenue growing?

Semilux International (SELX) revenue grew by 241.8% year-over-year, from $1.1M to $3.7M in fiscal year 2024.

Is Semilux International profitable?

No, Semilux International (SELX) reported a net income of -$3.7M in fiscal year 2024.

Semilux International (SELX) reported diluted earnings per share of -$0.10 for fiscal year 2024. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Semilux International (SELX) had EBITDA of -$5.0M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2024, Semilux International (SELX) had $3.6M in cash and equivalents against $938K in long-term debt.

Semilux International (SELX) had a gross margin of -23.7% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

Semilux International (SELX) has a return on equity of -645.1% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

Semilux International (SELX) recorded an outflow of $578K in free cash flow during fiscal year 2024. This represents a 71.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Semilux International (SELX) generated $66K in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

Semilux International (SELX) had $9.6M in total assets as of fiscal year 2024, including both current and long-term assets.

Semilux International (SELX) invested $644K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

Semilux International (SELX) invested $1.1M in research and development during fiscal year 2024.

Semilux International (SELX) had 38M shares outstanding as of fiscal year 2024.

Semilux International (SELX) had a current ratio of 1.07 as of fiscal year 2024, which is considered adequate.

Semilux International (SELX) had a debt-to-equity ratio of 1.65 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

Semilux International (SELX) had a return on assets of -38.3% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

Semilux International (SELX) has an Altman Z-Score of -1.08, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Semilux International (SELX) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Semilux International (SELX) reported a net loss of $3.7M while generating $66K in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Semilux International (SELX) reported an operating loss of $5.4M against $101K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Semilux International (SELX) scores 33 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top